Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCalnex Solutio. Regulatory News (CLX)

Share Price Information for Calnex Solutio. (CLX)

Share Price is delayed by 15 minutes
Get Live Data
68.50    0.00 (0.00%)
Bid:
67.00
Ask:
70.00
Spread: 3.00 (4.478%)
Market Cap: £60.33m
CLX Live PriceLast checked at - London Stock Exchange

Intraday Calnex Solutio. Share Chart

Directorate Change

27 Jul 2006 07:00

Calyx Group PLC27 July 2006 For immediate release 27 July 2006 Calyx Group PLC ("Calyx" or "the Company") Appointment of Chief Financial Officer Calyx, the largest single-source provider of information and communicationtechnology ("ICT") network solutions throughout Ireland, and who recentlyannounced the acquisition of the Matrix Companies for up to £40.5 million, istoday pleased to announce the appointment of Peter Lewis Jenkins ("Peter") asChief Financial Officer ("CFO") and main board director of the Company. Thisappointment will be effective from 21 August 2006. Peter (48) co-founded Numerica Group plc as Group Finance Director in 2001 andwas Chief Executive Officer from March 2004 to June 2005, at which time thegroup was acquired by Vantis plc. Prior to joining Calyx Peter has been InterimChief Financial Officer of Fujin Technology plc (formerly known as MatrixCommunications Group plc) He is currently a director of Demyst Limited and was adirector of VoxIQ Limited. Peter qualified as a Chartered Accountant in 1981 and following seven yearsworking in accountancy firms (Neville Russell and Coopers & Lybrand) he movedinto industry and commerce. He has held senior financial positions at LexService plc, Coca-Cola & Schweppes Beverages Ltd and Harrisons & Crosfield plc.He was also Group Finance Director of Regus plc from 1998 - 2000. Peter has been a Council member of the Institute of Chartered Accountants inEngland and Wales since 2003 and he was a member of its Audit Committee from2003 to 2005. He also holds a degree in Economics and Statistics fromSouthampton University. The contents of this announcement include the full disclosures required underSchedule 2, Para (g) of the AIM and IEX Rules. Commenting on the appointment Maurice Healy, Chief Executive of Calyx said: "I am delighted to be announcing the appointment of Peter today. With overfifteen years of senior management experience, he will provide us with excellentcorporate governance counsel and has an extensive track record in M&A activity.He joins at an exciting period of growth for Calyx as we look to expand ouroperations in the UK and consolidate our leading position in Ireland. Theaddition of Peter to our executive management team along with the other recentboard appointments ensures we have the right team in place to continue thegrowth and development of the group. For further details please contact: Calyx Group plc Tel: +353 1 676 3363Maurice Healy, Chief Executive Buchanan Communications Tel: +44 (0)20 7466 5000Jeremy Garcia This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jun 20267:30 amRNSDirector Dealing
29th May 20263:00 pmRNSExercise of Options and Total Voting Rights
26th May 20267:00 amRNSFinal Results
14th May 20267:00 amRNSNotice of Presentations
13th Apr 20267:00 amRNSFY26 Trading Update and Notice of Results
30th Mar 20267:00 amRNSHolding(s) in Company
26th Nov 20257:30 amRNSDirector Dealing
18th Nov 20257:00 amRNSInterim Results
6th Nov 202511:30 amRNS-RCalnex and Viavi Partnership
30th Oct 20257:00 amRNSNotice of Results and Presentations
8th Oct 20252:08 pmRNSExercise of Options and Total Voting Rights
16th Sep 20259:09 amRNSExercise of Options and Total Voting Rights
14th Aug 20254:12 pmRNSResult of AGM
14th Aug 20257:00 amRNSAGM Statement
15th Jul 20257:00 amRNSNotice of AGM and posting of Annual Report
16th Jun 20259:52 amRNSLong-Term Incentive Plan Awards
10th Jun 202511:59 amRNSDirector Dealing
20th May 20257:00 amRNSFinal Results
15th May 20257:00 amRNSNotice of Investor Presentation
8th Apr 20257:00 amRNSFY25 Trading Update and Notice of Results
14th Mar 20257:00 amRNSDirector Dealing
29th Jan 202510:48 amRNSExercise of Options
19th Nov 20247:00 amRNSInterim Results
4th Nov 20247:00 amRNSNotice of Results and Investor Presentation
8th Oct 20247:00 amRNSDirector/PDMR Dealing
2nd Oct 20244:57 pmRNSResult of General Meeting
6th Sep 20247:00 amRNSNotice of General Meeting
22nd Aug 20245:18 pmRNSResult of AGM
22nd Aug 20247:00 amRNSAGM Statement
18th Jul 20249:08 amRNSNotice of AGM
17th Jul 20242:00 pmRNSLong-Term Incentive Plan Awards
21st May 20247:00 amRNSFY24 Final Results
10th Apr 20247:00 amRNSNotice of Investor Presentation
3rd Apr 20247:00 amRNSFY24 Trading Update and Notice of Results
21st Feb 20249:28 amRNSExercise of Options
14th Feb 20241:08 pmRNSExercise of Options
12th Dec 20233:47 pmRNSPDMR Dealings
21st Nov 20237:00 amRNSInterim Results
1st Nov 202312:24 pmRNSChange of Nominated Adviser
26th Oct 20237:00 amRNSNotice of Investor Presentation
10th Oct 20233:17 pmRNSTrading Update and Notice of Results
25th Aug 20234:36 pmRNSPDMR Dealings
16th Aug 20231:22 pmRNSResult of AGM
16th Aug 20237:00 amRNSAGM Statement
11th Aug 20232:00 pmRNSLong-Term Incentive Plan Awards
17th Jul 20237:00 amRNSNotice of AGM
12th Jul 202312:05 pmRNSDirector/PDMR Dealings
12th Jun 20234:34 pmRNSPDMR Dealings
23rd May 20237:00 amRNSFY23 Final Results
11th May 20239:00 amRNSPDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.